Sezary disease, in remission, is a rare type of cutaneous T-cell lymphoma characterized by erythroderma, lymphadenopathy, and circulating malignant T-cells. It is crucial for accurate diagnosis and documentation to ensure appropriate treatment and billing. The ICD-10 Code C84.1A facilitates precise coding for healthcare providers, ensuring compliance with billing standards and aiding in public health reporting.
ICD-10 Code C84.1A represents Sezary disease, in remission, a condition where patients exhibit signs of cutaneous T-cell lymphoma but are currently not experiencing active symptoms. This code is used in clinical documentation and billing to indicate the patient's status, ensuring that healthcare providers can accurately report the condition for treatment and reimbursement purposes.
Sezary disease, in remission, is a stage of cutaneous T-cell lymphoma where the disease is not actively progressing. It is characterized by the presence of malignant T-cells in the blood and skin, requiring ongoing monitoring and management. Medical attention is essential to prevent potential relapses.
ICD-10 Code C84.1A is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C84.1A connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of Sezary disease, in remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Sezary disease, in remission, focuses on monitoring and supportive care to prevent relapse and manage symptoms.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.1A is essential for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with differential. |
| 11100 | Biopsy of skin, single lesion. |
| 99214 | Established patient office visit, high complexity. |
Common Questions About Using ICD-10 Code C84.1A for Sezary disease, in remission
What are the symptoms of Sezary disease, in remission?
Patients in remission typically do not exhibit active symptoms such as skin lesions or lymphadenopathy. However, they may have a history of these symptoms and require ongoing monitoring to prevent relapse.
How is Sezary disease, in remission treated?
Treatment focuses on supportive care, including skin management and monitoring for signs of relapse. Regular follow-ups with dermatology are essential to ensure the patient's condition remains stable.
When should ICD-10 Code C84.1A be used?
This code should be used when documenting a patient with Sezary disease who is currently in remission, indicating that they are not experiencing active symptoms but require ongoing management.
What is the importance of accurate coding for Sezary disease?
Accurate coding ensures appropriate reimbursement for healthcare services, facilitates effective patient management, and supports public health reporting efforts related to cutaneous T-cell lymphomas.
Clinical Notes
SOAP notes
DAP notes
AI medical notes